Home/Idience/Won Sik Lee, MD, Ph.D.

WS

Won Sik Lee, MD, Ph.D.

Chief Executive Officer

Therapeutic Areas

Idience Pipeline

Drug	Indication	Phase
Venadaparib (IDX-1197)	Gastric Cancer	Phase 1b/2a

Leadership Team at Idience

Kyoung Soo Ha, MD, Ph.D.

Chief Medical Officer

Eun Kyung Kang, R.Ph, MPH

Chief Regulatory and Quality Officer

View full Idience profile